In another cancer-related study, miR-145-5p inhibited tumor angiogenesis by targeting serpin family E member 1 (SERPINE1), a positive regulator for the VEGFR-2 signaling pathway (Teng et al., 2021). Here, SERPINE1 is linked to cancer.